Bruker (NASDAQ:BRKR – Get Free Report) had its price target lowered by stock analysts at Barclays from $69.00 to $65.00 in a research note issued on Monday,Benzinga reports. The firm currently has an ...

Bruker Corporation (Nasdaq: BRKR) today announced it will report fourth quarter and fiscal year 2024 financial results before ...

Bruker Corporation today announced the launch of the VERTEX NEO Platform today with its first product, the VERTEX NEO R. This ...

Barclays analyst Luke Sergott lowered the firm’s price target on Bruker to $65 from $69 and keeps an Overweight rating on the shares. The firm ...

In a report released today, Brandon Couillard from Wells Fargo maintained a Buy rating on Bruker (BRKR – Research Report), with a price target ...

Genomics company 10x and Harvard University have agreed to resolve a patent lawsuit against 10x's rival Vizgen four days into ...

After the National Institutes of Health (NIH) announced late Friday that it would be following a Trump administration ...

Bruker shares fell by 2.5%, Illumina by 3.3%, Quanterix by 2.8%, Bio-Techne by 5%, 10X Genomics by 8.8%, and Qiagen by 3.5%. Analysts have noted that this move by the NIH could have a material impact ...

A 15-minute drive away from IU’s campus lies Lake Monroe, Indiana’s largest man-made body of water and a major source of ...

Industry growth reports; new GF CEO; UVM for mixed signal; power demands explode; EU-US chip collaboration; earnings; S Korea ...